CONSENSI Trademark

Trademark Overview

On Tuesday, January 10, 2017, a trademark application was filed for CONSENSI with the United States Patent and Trademark Office. The USPTO has given the CONSENSI trademark a serial number of 87295108. The federal status of this trademark filing is REGISTERED as of Tuesday, June 2, 2020. This trademark is owned by Kitov Pharmaceuticals Ltd.. The CONSENSI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, nonsteroidal anti-inflammatory drug combined with calcium channel blocker
consensi

General Information

Serial Number87295108
Word MarkCONSENSI
Filing DateTuesday, January 10, 2017
Status700 - REGISTERED
Status DateTuesday, June 2, 2020
Registration Number6069735
Registration DateTuesday, June 2, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, nonsteroidal anti-inflammatory drug combined with calcium channel blocker

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 17, 2017
Primary Code005
First Use Anywhere DateMonday, March 16, 2020
First Use In Commerce DateMonday, March 16, 2020

Trademark Owner History

Party NameKITOV PHARMA LTD.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWASHINGTON, DC 20007
Party NameKITOV PHARMA LTD.
Party Type22 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressWASHINGTON, DC 20007
Party NameKITOV PHARMACEUTICALS HOLDINGS LTD
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressWASHINGTON, DC 20007
Party NameKitov Pharmaceuticals Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWashington, DC 20007
Party NameKitov Pharmaceuticals Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWashington, DC 20007

Trademark Events

Event DateEvent Description
Tuesday, June 2, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, April 29, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 28, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 7, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 19, 2020USE AMENDMENT FILED
Monday, April 6, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 19, 2020TEAS STATEMENT OF USE RECEIVED
Friday, January 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 22, 2020EXTENSION 4 GRANTED
Wednesday, January 22, 2020EXTENSION 4 FILED
Wednesday, January 22, 2020TEAS EXTENSION RECEIVED
Wednesday, July 17, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 17, 2019EXTENSION 3 GRANTED
Wednesday, July 17, 2019EXTENSION 3 FILED
Wednesday, July 17, 2019TEAS EXTENSION RECEIVED
Tuesday, January 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 4, 2019EXTENSION 2 GRANTED
Friday, January 4, 2019EXTENSION 2 FILED
Friday, January 4, 2019TEAS EXTENSION RECEIVED
Thursday, June 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 5, 2018EXTENSION 1 GRANTED
Tuesday, June 5, 2018EXTENSION 1 FILED
Tuesday, June 5, 2018TEAS EXTENSION RECEIVED
Wednesday, March 7, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 21, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 23, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 2, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 2, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 2, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 7, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 7, 2017NON-FINAL ACTION E-MAILED
Friday, April 7, 2017NON-FINAL ACTION WRITTEN
Tuesday, April 4, 2017ASSIGNED TO EXAMINER
Tuesday, January 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 13, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

consensi combined calcium channel blocker drug inflammatory preparations namely nonsteroidal anti